Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7729-94-4

Post Buying Request

7729-94-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7729-94-4 Usage

Chemical Properties

White Solid

Uses

A hydrochloride salt metabolite of Lidocaine (L397800).

Check Digit Verification of cas no

The CAS Registry Mumber 7729-94-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,2 and 9 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 7729-94:
(6*7)+(5*7)+(4*2)+(3*9)+(2*9)+(1*4)=134
134 % 10 = 4
So 7729-94-4 is a valid CAS Registry Number.

7729-94-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name N-(2,6-Dimethylphenyl)-N<sup>2</sup>-ethylglycinamide hydrochloride (1:1)

1.2 Other means of identification

Product number -
Other names N-Ethylglycinhydrochlorid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7729-94-4 SDS

7729-94-4Downstream Products

7729-94-4Relevant articles and documents

BENZYLPHOSPHATE AND SUBSTITUTED BENZYLPHOSPHATE PRODRUGS FOR TRE TREATMENT OF PULMONARY INFLAMMATION

-

Page/Page column 44, (2010/02/12)

A prodrug of a corticosteroid, lidocaine or related local anesthetic composition for formulation for delivery by aerosolization to inhibit inflammation in asthmatic lungs is described. The prodrug is preferably formulated in a 5 ml solution of a quarter normal saline having pH between 5.0 and 7.0 for the treatment of respiratory tract inflammation by an aerosol having mass medium average diameter predominantly between 1 to 5 μ produced by nebulization or dry powder inhaler.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7729-94-4